Molina Healthcare
MOH NYSE· Managed Health Care
Last close · Oct 27, 2026
$199.46
KIRA · Stoqly’s AI analyst, in plain words
- Molina Healthcare had $45.4B of revenue in fiscal 2025, up 11.8% on the year before. Over five years, revenue changed +18.5% a year on average.
- Its operating margin was 1.7%, down 2.5 pts: of every 100 in sales, about 2 is left after running the business.
- Molina Healthcare made $472M of net profit in fiscal 2025. From fiscal 2016 to 2025, diluted EPS grew 28.7% a year.
- Free cash flow was −$636M in fiscal 2025, −1.4% of revenue.
- Molina Healthcare returned $1.0B to shareholders in fiscal 2025. The diluted share count fell 8.3%.
- Molina Healthcare has $4.3B more cash than debt.
Market cap
$10.3B
P/E
—
Revenue
$45.4B
Net income
$472M
Free cash flow
−$636M
Operating margin
1.7%
Molina Healthcare in 30 seconds · fiscal 2025
Are sales growing?
+11.8%
Yes. Sales grew 11.8% last year.
Does it make a profit?
1.0%
A little. It keeps 1.0% of every sale as profit.
Does profit turn into cash?
−1.4%
No. It spent more cash than it brought in.
Is debt under control?
Net cash
Yes. It has more cash than debt.
How healthy are the accounts?
4 / 8
Mixed. It passes 4 of 8 health tests.
What Molina Healthcare does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Feb 10, 2026
- Legal name
- MOLINA HEALTHCARE, INC.
- CIK
- 0001179929
Molina Healthcare · MOH
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $27.8B | $32.0B | $34.1B | $40.7B | $45.4B |
| Revenue growth | 43.0% | 15.1% | 6.6% | 19.3% | 11.8% |
| Operating margin | 3.7% | 3.7% | 4.6% | 4.2% | 1.7% |
| Net income | $659M | $792M | $1.1B | $1.2B | $472M |
| Net margin | 2.4% | 2.5% | 3.2% | 2.9% | 1.0% |
| Diluted EPS | $11.25 | $13.55 | $18.77 | $20.42 | $8.92 |
| Cash | |||||
| Cash from operations | $2.1B | $773M | $1.7B | $644M | −$535M |
| Capital expenditure | $77.0M | $91.0M | $84.0M | $100M | $101M |
| Free cash flow | $2.0B | $682M | $1.6B | $544M | −$636M |
| FCF margin | 7.4% | 2.1% | 4.6% | 1.3% | −1.4% |
| Dividends paid | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Share buybacks | $128M | $400M | $0.0M | $1.0B | $1.0B |
| Share count change | −2.2% | −0.2% | −0.7% | −0.7% | −8.3% |
| Debt and strength | |||||
| Cash and short-term investments | $7.6B | $7.5B | $9.1B | $9.0B | $8.3B |
| Debt incl. finance leases | $2.4B | $2.4B | $2.4B | $3.1B | $4.0B |
| Shareholders' equity | $2.6B | $3.0B | $4.2B | $4.5B | $4.1B |
| Net debt / EBITDA | −4.6x | −3.8x | −3.8x | −3.1x | −4.4x |
| Current ratio | 1.4x | 1.5x | 1.5x | 1.6x | 1.7x |
| Interest coverage | 8.5x | 10.7x | 14.4x | 14.5x | 4.1x |
| Returns and quality | |||||
| Return on equity | 27.9% | 28.3% | 30.4% | 27.1% | 11.0% |
| Piotroski F-score | 6 | 5 | 8 | 4 | 4 |
| Altman Z'' | 3.1 | 3.4 | 3.9 | 4.1 | 3.6 |
Insiders bought, 12 months
$0.1M
1 insider
Insiders sold, 12 months
$3.6M
4 insiders
Of sales under plans
0%
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Molina Healthcare · MOH
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
Similar companies
Each company’s latest fiscal year. Fiscal years end in different months, so periods don’t line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score |
|---|---|---|---|---|---|---|---|
| Molina Healthcare MOH | $10.3B | 11.8% | 1.7% | −1.4% | — | — | 4 |
| Humana HUM | $50.1B | 10.1% | 2.1% | 0.3% | 25.7% | 44.3x | 5 |
| Oscar Health OSCR | $10.5B | 27.5% | −3.4% | 9.1% | — | 24.1x | 4 |
| Centene CNC | $34.2B | 19.4% | −3.9% | 2.2% | −26.4% | — | 5 |
| Elevance Health ELV | $91.7B | 12.5% | 3.6% | 1.6% | 15.2% | 17.9x | 6 |
KIRA
At $199.46 a share, the company is worth $10.3B.
Molina Healthcare grew sales faster than 1 of its 4 similar companies.
Source: SEC EDGAR XBRL filings (CIK 0001179929). Data updated October 22, 2026. For information only — not investment advice. Check the original filings before relying on any figure.